首页> 美国卫生研究院文献>Drug Metabolism and Disposition >Targeted Precise Quantification of 12 Human Recombinant Uridine-Diphosphate Glucuronosyl Transferase 1A and 2B Isoforms Using Nano-Ultra-High-Performance Liquid Chromatography/Tandem Mass Spectrometry with Selected Reaction Monitoring
【2h】

Targeted Precise Quantification of 12 Human Recombinant Uridine-Diphosphate Glucuronosyl Transferase 1A and 2B Isoforms Using Nano-Ultra-High-Performance Liquid Chromatography/Tandem Mass Spectrometry with Selected Reaction Monitoring

机译:使用纳米超高效液相色谱/串联质谱法和选定的反应监测技术对12种人类重组尿嘧啶二磷酸葡萄糖苷葡萄糖基转移酶1A和2B同工型进行精确定量靶向分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Quantification methods employing stable isotope-labeled peptide standards and liquid chromatography–tandem mass spectrometry are increasingly being used to measure enzyme amounts in biologic samples. Isoform concentrations, combined with catalytic information, can be used in absorption, distribution, metabolism, and excretion studies to improve accuracy of in vitro/in vivo predictions. We quantified isoforms of uridine-diphosphate glucuronosyltransferase (UGT) 1A and 2B in 12 commercially available recombinant UGTs (recUGTs) (n = 49 samples) using nano-ultra-high-performance liquid chromatography–tandem mass spectrometry with selected reaction monitoring). Samples were trypsin-digested and analyzed using our previously published method. Two MRMs were collected per peptide and averaged. Where available, at least two peptides were measured per UGT isoform. The assay could detect UGTs in all recombinant preparations: recUGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B15, and 2B17, with limit of detection below 1.0 pmol/mg protein for all isoforms. The assay had excellent linearity in the range observed (2–15.5 pmol/mg, after dilution). Examples of concentrations determined were 1465, 537, 538, 944, 865, 698, 604, 791, 382, 1149, 307, and 740 pmol/mg protein for the respective isoforms. There was a 6.9-fold difference between the maximum and minimum recUGT concentrations. The range of concentrations determined indicates that catalytic rates per mg total protein in vitro will not accurately reflect isoform inherent specific activity for a particular drug candidate. This is the first report of a targeted precise quantification of commercially available recUGTs. The assay has potential for use in comparing UGT amounts with catalytic activity determined using probe substrates, thus allowing representation of catalysis as per pmol of UGT isoform.
机译:采用稳定同位素标记的肽标准品和液相色谱-串联质谱的定量方法正越来越多地用于测量生物样品中的酶含量。异构体浓度与催化信息结合可用于吸收,分布,代谢和排泄研究,以提高体外/体内预测的准确性。我们使用纳米超高效液相色谱-串联质谱联用选定的反应监测方法,对12种市售重组UGT(recUGT)(n = 49个样品)中的尿苷-二磷酸葡萄糖醛酸糖基转移酶(UGT)1A和2B的同工型进行了定量。使用胰蛋白酶消化样品,并使用我们先前发布的方法进行分析。每个肽收集两个MRM并取平均值。如果可以的话,每个UGT同工型至少测量两个肽。该测定法可以检测所有重组制剂中的UGT:recUGT 1A1、1A3、1A4、1A6、1A7、1A8、1A9、1A10、2B4、2B7、2B15和2B17,所有同工型的检测限均低于1.0 pmol / mg蛋白。该测定法在观察到的范围内具有出色的线性度(稀释后为2-15.5 pmol / mg)。所测定浓度的实例是相应同工型的1465、537、538、944、865、698、604、791、382、1149、307和740 pmol / mg蛋白。 recUGT的最大和最小浓度之间有6.9倍的差异。确定的浓度范围表明,体外每毫克总蛋白的催化速率将无法准确反映特定药物候选物的同工型固有比活性。这是针对市售RecUGT进行精确定量分析的第一份报告。该测定法具有将UGT量与使用探针底物测定的催化活性进行比较的潜力,因此可以表示为每pmol UGT亚型催化。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号